Axillary lymphangioma that developed following COVID-19 vaccination: a case report.
Surg Case Rep
; 8(1): 131, 2022 Jul 08.
Article
in English
| MEDLINE | ID: covidwho-1923587
ABSTRACT
BACKGROUND:
Extensive vaccination programs are being implemented worldwide for coronavirus disease 2019 (COVID-19). With the spread of vaccination, swelling of the lymph nodes after vaccination is frequently seen. We encountered a patient who developed left axillary lymphadenoma following vaccine administration. CASE PRESENTATION The patient was a Japanese woman in her 80 s who had previously undergone surgery for right breast cancer. She received two injections of the Pfizer-BioNTech COVID-19 vaccine in her left arm. Approximately 3 months later, she complained of left axillary swelling, and imaging resulted in a diagnosis of left axillary lymphangioma. In accordance with the patient's wishes, we performed axillary mass resection. The pathological diagnosis was lymphangioma.CONCLUSION:
Our examination findings indicated that congestion of the axillary lymph vessels might have been caused by upper-arm injections of the COVID-19 vaccine.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Topics:
Vaccines
Language:
English
Journal:
Surg Case Rep
Year:
2022
Document Type:
Article
Affiliation country:
S40792-022-01488-5
Similar
MEDLINE
...
LILACS
LIS